AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 282: H2198-H2209, 2002. First published February 21, 2002; doi:10.1152/ajpheart.00834.2001
0363-6135/02 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/6/H2198    most recent
00834.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haitsma, D. B.
Right arrow Articles by Duncker, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haitsma, D. B.
Right arrow Articles by Duncker, D. J.
Vol. 282, Issue 6, H2198-H2209, June 2002

Nitric oxide production is maintained in exercising swine with chronic left ventricular dysfunction

David B. Haitsma, Daphne Merkus, Jefrey Vermeulen, Pieter D. Verdouw, and Dirk J. Duncker

1 Experimental Cardiology, Thoraxcenter, Erasmus University Rotterdam, 3000 DR Rotterdam, The Netherlands


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Left ventricular (LV) dysfunction caused by myocardial infarction (MI) is accompanied by endothelial dysfunction, most notably a loss of nitric oxide (NO) availability. We tested the hypothesis that endothelial dysfunction contributes to impaired tissue perfusion during increased metabolic demands as produced by exercise, and we determined the contribution of NO to regulation of regional systemic, pulmonary, and coronary vasomotor tone in exercising swine with LV dysfunction produced by a 2- to 3-wk-old MI. LV dysfunction resulted in blunted systemic and coronary vasodilator responses to ATP, whereas the responses to nitroprusside were maintained. Exercise resulted in blunted systemic and pulmonary vasodilator responses in MI that resembled the vasodilator responses in normal (N) swine following blockade of NO synthase with Nomega -nitro-L-arginine (L-NNA, 20 mg/kg iv). However, L-NNA resulted in similar decreases in systemic (43 ± 3% in N swine and 49 ± 4% in MI swine), pulmonary (45 ± 5% in N swine and 49 ± 4% in MI swine), and coronary (28 ± 4% in N and 35 ± 3% in MI) vascular conductances in N and MI swine under resting conditions; similar effects were observed during treadmill exercise. Selective inhibition of inducible NO synthase with aminoguanidine (20 mg/kg iv) had no effect on vascular tone in MI. These findings indicate that while agonist-induced vasodilation is already blunted early after myocardial infarction, the contribution of endothelial NO synthase-derived NO to regulation of vascular tone under basal conditions and during exercise is maintained.

coronary circulation; myocardial infarction; pulmonary circulation; regional blood flows; systemic circulation


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

HEART FAILURE is accompanied by increased production of neurohormones such as norepinephrine, angiotensin II, and endothelin (19, 50), which serves to maintain arterial pressure by partially restoring cardiac output and increasing peripheral vascular resistance, to maintain perfusion of essential tissues like the brain and heart at the expense of renal, pancreatic, and intestinal blood flow. Several studies have indicated that also endothelial dysfunction, in particular a decreased production of nitric oxide (NO), contributes to an increased peripheral resistance in congestive heart failure (18, 25, 29, 32, 58). A loss of NO availability could aggravate left ventricular (LV) dysfunction due to the peripheral vasoconstriction-induced increase in LV afterload, coronary vasoconstriction, and increased myocardial O2 consumption (15, 34, 47, 58). In support of this concept, a decreased NO production coincides with the transition of LV dysfunction to overt congestive heart failure in models of pacing-induced heart failure (47, 58).

Clinically, the most common cause for heart failure is myocardial infarction (MI). Studies on the role of NO in the regulation of vasomotor tone in MI-induced LV dysfunction in rats indicate that between 4 and 16 wk after infarction, acetylcholine- or ADP-induced NO-mediated relaxation of systemic conductance arteries (4, 40, 43, 53, 57) and resistance vessels (13) is reduced, although this is not an unequivocal finding (2, 6). In contrast, basal NO production is maintained in systemic conductance arteries (2, 43) and in resistance vessels in various regional vascular beds in vivo (6, 10, 13, 21). These findings could be interpreted to suggest that early after infarction, a reduced NO-mediated vasodilator capacity could contribute to a blunted vasodilator response, and hence tissue hypoperfusion during exercise (9) at a time when basal NO production is still intact. Recently, Duncker et al. (15) reported that in resting and exercising normal swine, inhibition of NO synthase with Nomega -nitro-L-arginine (L-NNA) decreased systemic and pulmonary vascular conductance and decreased flow to the kidney, pancreas, and part of the gut, whereas flow to the skeletal muscle was unaffected. A similar pattern was found in exercising swine with a 3-wk-old MI (24), suggesting that in this model of moderate LV dysfunction, NO availability is already impaired, in particular during exercise. Consequently, we tested in the present study the hypothesis that loss of NO-mediated vasodilation contributes to abnormalities in vascular tone control in regional systemic, pulmonary, and coronary beds in exercising swine with LV dysfunction after MI. Because our results indicated that the contribution of NO to exercise-induced vasodilation was maintained, and because inducible NO synthase (iNOS) may be upregulated after infarction (12, 52), we further tested whether upregulation of iNOS compensated for the potential loss of endothelial NO synthase (eNOS) activity.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Studies were performed in accordance with the Guide for the Care and Use of Laboratory Animals (NIH Publication 86-23, Revised 1985) and with approval of the Animal Care Committee of the Erasmus University Rotterdam. Thirty-six 2- to 3-mo-old Yorkshire × Landrace swine (22 ± 1 kg at the time of surgery) of either sex entered the study; 22 swine were designated to the MI group and 14 to the normal group (N). Results from 11 of 14 N have been previously reported (15). Daily adaptation of animals to laboratory conditions started 1 wk before surgery.

Surgical Procedures

Swine were sedated (ketamine, 20 mg/kg im), anesthetized (thiopental, 10 mg/kg iv), intubated, and ventilated with O2 and N2O to which 0.2%-1% (vol/vol) isoflurane was added (14, 16, 17, 56). Anesthesia was maintained with midazolam (2 mg/kg followed by 1 mg · kg-1 · h-1 iv, for 2 h) and fentanyl (5-10 µg · kg-1 · h-1 iv). Under sterile conditions, the chest was opened via the fourth left intercostal space, and a fluid-filled polyvinylchloride catheter was inserted into the aortic arch for aortic blood pressure measurement (Combitrans pressure transducers, Braun) and blood sampling for determination of blood gases (Acid-Base Laboratory model 505, Radiometer), O2 saturation, and hemoglobin concentration (OSM2, Radiometer), and computation of O2 content, O2 supply, and O2 consumption (16, 17). An electromagnetic flow probe (14-15 mm, Skalar) was positioned around the ascending aorta for measurement of cardiac output. A microtipped pressure-transducer (P4.5, Konigsberg Instruments) was inserted into the LV via the apex. Polyvinylchloride catheters were inserted into the LV to calibrate the Konigsberg transducer LV pressure signal (16, 17) and into the left atrium to measure pressure and inject radioactive microspheres to determine regional blood flows (14). Catheters were inserted into the pulmonary artery to measure pressure, administer drugs, and collect mixed venous samples, while an angiocatheter was inserted into the anterior interventricular vein for blood sampling, and a Doppler flow probe (2.0-3.0 mm, Crystal Biotech) was placed around the left anterior descending coronary artery (16, 17). The proximal left circumflex coronary artery (LCx) was permanently occluded in 22 MI swine (56), which were monitored for 1 h and if needed internally defibrillated (10-30 J). Six MI swine died due to recurrent fibrillation. Catheters were tunneled to the back, and animals were allowed to recover, receiving analgesia (0.3 mg buprenorphine im) for 2 days and antibiotic prophylaxis (25 mg/kg amoxicillin and 5 mg/kg gentamycin iv) for 5 days (16, 17). Four MI swine died overnight during the first week after surgery.

Experimental Protocols

Agonist-induced vasodilation. The hemodynamic responses to the vasodilator ATP (50-200 µg · kg-1 · min-1 iv) were determined in five resting MI swine and compared with six N swine. ATP was employed instead of acetylcholine, because acetylcholine is less effective as an endothelium-dependent vasodilator in the porcine coronary circulation. We have previously shown in N swine (15) that vasodilation produced by these doses of ATP is virtually abolished by pretreatment with L-NNA (20 mg/kg iv), indicating that at these doses ATP produces vasodilation principally via NO. To study the responsiveness of the vascular beds to NO, we determined in the same animals the hemodynamic responses to the endothelium-independent NO donor sodium nitroprusside (SNP, 0.5-5 µg · kg-1 · min-1 iv).

Exercise. Central and regional systemic, pulmonary and coronary hemodynamic responses to exercise were studied in 14 N (29 ± 1 kg) and 12 MI (28 ± 1 kg) swine ~2-3 wk after surgery. After baseline measurements (lying, 0L, and standing, 0S) were obtained, a treadmill exercise protocol was begun (1-4 km/h); data were collected during the last 30 s of each 3-min exercise stage (16, 17). After completion of the exercise protocol the swine were allowed to rest for 90 min, and then L-NNA (20 mg/kg iv) was administered and the exercise protocol repeated (15).

On another day (separated by at least 4 days from the L-NNA protocol and performed in random order with the L-NNA protocol), the reproducibility of the responses to exercise was studied. Animals underwent a second control exercise trial 90 min after the first trial, as previously described (15-17).

On a different day (separated by at least 4 days from the L-NNA protocol), the exercise protocol was repeated in 4 MI swine, but before the second exercise protocol the iNOS inhibitor aminoguanidine [10- to 50-fold selectivity iNOS/eNOS (5, 61)] was administered in a dose of 20 mg/kg iv (infused in 15 min starting 30 min before exercise), which is in the dose range (10-30 mg/kg) that has been reported to produce a high degree of iNOS inhibition in rats (62), rabbits (59), and swine (64).

Regional Blood Flows

In seven N and seven MI swine, regional blood flows were determined on a separate day using the radioactive microsphere technique (14, 15). In N swine, radioactive microspheres were injected at rest (lying, 0L) and during exercise at 5 km/h, whereas in MI swine, microspheres were injected at rest (lying) and during exercise at 4 km/h [maximum treadmill speed for most MI (24)].

Data Analysis

Digital recording and off-line analysis of hemodynamics and regional blood flow have been described previously (14, 16, 17). Statistical analysis was performed using two-way (exercise level and infarction) analysis of variance (ANOVA) for repeated measures, followed by Dunnett's test (exercise effect) or unpaired t-test (MI vs. N). Analysis of covariance (ANCOVA) for repeated measures was used to detect statistically significant differences of relations between hemodynamic variables and body or myocardial O2 consumption (VO2) (with VO2 as a covariate) in MI versus N swine. Significance was accepted when P < 0.05. Data are means ± SE.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Cardiac Anatomic Data

Despite the loss of viable LV myocardial tissue due to infarction, the LV weight-to-body weight ratio was 15% higher than in normal swine (3.69 ± 0.16 vs. 3.18 ± 0.17 g/kg, P < 0.05). Right ventricular weight-to-body weight ratio was also higher in MI swine compared with N swine (1.71 ± 0.23 vs. 1.14 ± 0.13 g/kg, P < 0.05), which correlated well with the elevated pulmonary artery pressure in MI swine (r2 = 0.63; P < 0.05).

Agonist-Induced Vasodilation

The NO-dependent vasodilator ATP caused dose-dependent dilation of the systemic and coronary circulation (Fig. 1), but did not result in significant pulmonary vasodilation (not shown). At each dose of ATP, dilation was less in MI swine than in N swine, indicating either a reduced NO production, an increased NO degradation, or reduced vascular smooth muscle responsiveness to NO after MI. The vasodilator response of systemic and coronary vascular beds to the NO donor SNP were comparable in MI and N swine, suggesting that the blunted vasodilator response to ATP was not due to a reduced bioavailability or vascular responsiveness to NO.


View larger version (20K):
[in this window]
[in a new window]
  		Fig. 1.   Increases in systemic vascular conductance (SVC = cardiac output/mean arterial pressure) and coronary vascular conductance [CVC = coronary blood flow/(mean arterial pressure - mean left atrial pressure)] in myocardial infarction (MI) and normal (N) swine. Changes in CVC (Delta CVC) have been presented as % changes because of differences in baseline flow (see Table 1) due to the presence of left ventricular (LV) hypertrophy in MI (56). Note that ATP-induced vasodilation was blunted (P < 0.05 by ANOVA), whereas nitroprusside-induced vasodilation was maintained. Data are means ± SE.

Role of NO at Rest and During Exercise

Systemic circulation. Under resting conditions, L-NNA- induced inhibition of NO production caused peripheral vasoconstriction in both MI and N swine, as indicated by the decrease in systemic vascular conductance (SVC, Fig. 2). The systemic vasoconstriction markedly increased aortic blood pressure despite concomitant decrease in cardiac output. The latter was due to a decrease in heart rate, probably mediated by the baroreceptor reflex (Table 1). The decrease in cardiac output was accompanied by an increase in body O2 extraction so that whole body VO2 was maintained, resulting in a decrease in mixed venous PO2 (Fig. 2). These responses to L-NNA were similar in MI and N groups, indicating that the contribution of NO to the regulation of vasomotor tone in the systemic vascular bed was maintained 2-3 wk after infarction.


View larger version (23K):
[in this window]
[in a new window]
  		Fig. 2.   Effect of inhibition of nitric oxide (NO) synthase by Nomega -nitro-L-arginine (L-NNA, 20 mg/kg iv) on SVC at rest (0L, lying; 0S, standing) and during treadmill exercise (1-4 km/h; A) and on the relation between mixed venous PO2 at rest (lying) and during treadmill exercise (1-4 km/h; B) in MI and N swine. Data are means ± SE. VO2, O2 consumption. Dot inside a symbol denotes P < 0.05 vs. 0L; dagger P < 0.05 L-NNA vs. corresponding control; there were no significant differences in the responses to L-NNA between MI and N swine.


                              
View this table:
[in this window]
[in a new window]
  		Table 1.   Effects of NO synthase inhibition on hemodynamics in MI and N swine

In N swine, L-NNA blunted the exercise-induced increase in SVC (Delta SVC from 0L to 4 km/h) from 46 ± 2 ml · min-1 · mmHg-1 during control exercise to 32 ± 2 ml · min-1 · mmHg-1 during exercise in the presence of L-NNA (P < 0.05, Fig. 2). In MI, the exercise-induced increase in SVC (35 ± 3 ml · min-1 · mmHg-1, P < 0.05 vs. control run in N swine) resembled that in N swine after L-NNA. This should not be interpreted to suggest that a loss of NO production contributed to the blunted exercise-induced increase of SVC in MI, as L-NNA blunted the exercise-induced increase in SVC in MI swine (21 ± 2 ml · min-1 · mmHg-1) to the same extent as in N swine. Similarly, the effects of L-NNA on whole body O2 extraction and mixed venous PO2 were virtually identical in N and MI swine (Fig. 2), indicating that the contribution of NO to the exercise-induced vasodilation of the systemic vascular bed was unperturbed 2-3 wk after infarction.

Regional systemic vascular beds. L-NNA did not affect skeletal muscle blood flow in either N or MI group, either at rest or during exercise (Fig. 3). The exercise-induced decrease in blood flow to various abdominal organs was more pronounced in the MI swine than the N swine. However, the L-NNA-induced decrease in flow to these organs was not different between MI and N groups both at rest and during exercise.


View larger version (22K):
[in this window]
[in a new window]
  		Fig. 3.   Effect of inhibition of NO synthase by L-NNA (20 mg/kg iv) on regional blood flows at rest (lying) and during treadmill exercise at 4 km/h (MI) or at 5 km/h (N). Regional blood flows are plotted as a function of whole body O2 consumption (BVO2) to facilitate comparison of the exercise data obtained in MI (4 km/h) and N (5 km/h) swine. Data are means ± SE. Dot inside a symbol denotes P < 0.05 vs. 0L; dagger P < 0.05 L-NNA vs. corresponding control. There were no differences in the responses to L-NNA between MI and N swine either at rest or during exercise.

Coronary circulation. L-NNA decreased coronary vascular conductance (CVC) at rest and during exercise to a similar extent in MI and N swine (Table 1). The decrease in CVC was not simply the result of myogenic vasoconstriction secondary to the increase in aortic blood pressure, because it limited myocardial O2 supply thereby necessitating an increase in myocardial O2 extraction and resulting in a decrease of coronary venous PO2 (Fig. 4). Importantly, the effects of L-NNA on CVC, O2 extraction, and coronary venous PO2 were not different in the MI and N group, either at rest or during exercise, indicating that the contribution of NO to the regulation of vasomotor tone in the coronary resistance vessels was maintained in MI swine both at rest and during exercise.


View larger version (23K):
[in this window]
[in a new window]
  		Fig. 4.   Effect of inhibition of NO synthase by L-NNA (20 mg/kg iv) on myocardial O2 extraction and coronary venous PO2 at rest (lying) and during treadmill exercise (1-4 km/h) in MI and N swine. MVO2, myocardial O2 consumption. Data are means ± SE. Dot inside a symbol denotes P < 0.05 vs. 0L; dagger P < 0.05 L-NNA vs. control; there were no significant differences in the responses to L-NNA between MI and N swine either at rest or during exercise.

Pulmonary circulation. L-NNA produced similar increases in mean pulmonary arterial pressure (MPAP) and decreases in pulmonary vascular conductance (PVC) in MI and N groups under resting conditions (Table 1, Fig. 5). In the N group, L-NNA blunted the exercise-induced increase in PVC (Delta PVC from 0L to 4 km/h) from 119 ± 40 ml · min-1 · mmHg-1 during control exercise (P < 0.05) to 53 ± 33 ml · min-1 · mmHg-1 during exercise in the presence of L-NNA (Fig. 5). In MI swine, the exercise-induced increase in PVC (48 ± 22 ml · min-1 · mmHg-1) resembled that in the N swine after L-NNA, suggesting that a loss of NO production contributed to the blunted exercise-induced increase in PVC in MI swine. However, the effects of L-NNA on PVC during exercise were similar in MI and N swine. These findings indicate that the contribution of NO to basal tone and the exercise-induced vasodilation of the pulmonary resistance vessels is unperturbed 2-3 wk after infarction.


View larger version (23K):
[in this window]
[in a new window]
  		Fig. 5.   Effect of inhibition of NO synthase by L-NNA (20 mg/kg iv) on pulmonary vascular conductance [cardiac output/(mean pulmonary artery pressure - mean left atrial pressure)] at rest (0L, lying; 0S, standing) and during treadmill exercise (1-4 km/h) in MI and N swine. Data are means ± SE. Dot inside a symbol denotes P < 0.05 vs. 0L; dagger P < 0.05 L-NNA vs. Control; there were no significant differences in the responses to L-NNA between MI and N swine.

Contribution of iNOS

Because L-NNA in the dose used inhibits both eNOS and iNOS, we used the specific iNOS inhibitor aminoguanidine to determine whether increased levels of iNOS-derived NO acted to compensate for a loss of eNOS-derived NO. Aminoguanidine did not have any effect on systemic and coronary vascular conductance or on whole body and myocardial O2 extraction either at rest or during exercise (Table 2), indicating that NO production by iNOS influenced neither basal tone nor exercise-induced vasodilation 2-3 wk after infarction.

                              
View this table:
[in this window]
[in a new window]
  		Table 2.   Effects of inducible NO synthase inhibition on hemodynamics in MI swine

Reproducibility of the Responses to Exercise

Ninety minutes after the first control exercise period, at a time when all hemodynamic variables had returned to baseline resting values, a second period of exercise resulted in virtually identical hemodynamic responses to exercise (Table 3).

                              
View this table:
[in this window]
[in a new window]
  		Table 3.   Reproducibility of systemic hemodynamic responses to exercise in MI and N swine


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The major findings of the present study are that in swine with LV dysfunction due to a 2- to 3-wk-old MI: 1) agonist-induced receptor-mediated NO production was blunted compared with normal swine, whereas the vasodilator response to the endothelium-independent but NO-mediated vasodilation by nitroprusside was maintained; 2) inhibition of NO production by L-NNA resulted in similar increments in vascular tone compared with normal swine in the (regional) systemic, pulmonary, and coronary beds under basal resting conditions as well as during exercise up to 85% of maximum heart rate; and 3) inhibition of NO production by iNOS had no effect on vascular tone in the systemic, pulmonary, and coronary beds either at rest or during exercise.

Endothelial Dysfunction and Heart Failure

Agonist-induced vasodilation. Advanced heart failure is associated with endothelial dysfunction, in particular, a reduced biological availability of NO. Thus clinical studies have shown that chronic heart failure is accompanied by blunted vasodilator responses to endothelium-dependent, receptor-mediated vasodilators (particularly acetylcholine) in the microcirculation of the LV myocardium (55), leg (25, 30), and forearm (3, 11, 28, 33, 41). In the canine model of pacing-induced end-stage congestive heart failure, attenuated vasodilator responses of resistance vessels to acetylcholine in vivo have also been observed in the microvasculature of the hindleg circulation (13, 35) and the coronary circulation (58). Also, in rats with MI-induced LV dysfunction, vasodilator responses in the microcirculation of the hindlimb to acetylcholine were blunted 10 wk after infarction (13), although this was not confirmed in another study at 1, 2, 3, 5, and 13 wk after infarction in rats (58). An explanation for the discrepancy between the two studies is not readily found but may be related to the use of blood (13), a scavenger of NO, versus buffered solution (58) for perfusion of the hindlimb. In the present study we also observed reduced vasodilator responses in the systemic and coronary microvasculature to ATP in doses that we have previously shown to be completely abolished by pretreatment with L-NNA (15). These findings of a blunted ATP-induced vasodilation are in agreement with the hypothesis that agonist-induced NO synthase-mediated NO production is blunted 2-3 wk after MI, but could also be explained by a decreased biological availability of NO or a reduced vascular smooth muscle responsiveness to NO. Thus, whereas several clinical studies reported that the responses to nitroglycerine or nitroprusside were maintained in patients with chronic heart failure (11, 25, 28, 39), other studies reported a blunted vasodilator response to these NO donors (30, 33, 41). The severity of heart failure may underlie these equivocal findings because Bank et al. (3) observed blunted vasodilator responses to methacholine in the forearm of patients with mild or severe heart failure, whereas nitroprusside-induced vasodilation was blunted only in patients with severe heart failure. In agreement with this notion, the vasodilation by nitroglycerine or nitroprusside was maintained in LV dysfunction produced by MI (10, 13, present study), whereas vasodilation by nitroglycerine was blunted in the model of pacing-induced end-stage heart failure (58). This reduction in vasodilator response to NO donors could result from a decreased vascular smooth muscle responsiveness to NO or from a reduced half-life of NO due to increased levels of NO scavenging substances such as O<UP><SUB>2</SUB><SUP>−</SUP></UP>, which may be increased in chronic severe heart failure in part due to an increased production of tumor necrosis factor-alpha (22).

The preserved nitroprusside-induced vasodilation in the present study indicates that NO degradation and vascular smooth muscle responsiveness to NO were normal in MI. Therefore, the blunted vasodilator response to ATP is in agreement with the hypothesis that endothelial NO production in response to ATP was attenuated. However, it could be argued that in MI, accelerated ATP breakdown contributed to the attenuated vasodilation that was observed during ATP infusion in the MI group compared with the N group. Indeed, one cannot exclude that following administration of endothelium-dependent vasodilators such as acetylcholine, substance P, bradykinin, and ADP (endogenous compounds that are usually employed to assess endothelial function in heart failure), increased breakdown of these compounds contributes to the blunted vasodilator response. In previous experiments we observed in normal animals that the vasodilation in response to intravenous infusion of ATP in doses of 50-200 µg · kg-1 · min-1 was abolished by L-NNA both in the systemic and coronary vascular beds, indicating that at these doses ATP produces vasodilation exclusively via NO synthase-mediated NO production (15). Part of this vasodilation could be due to the production of ADP and adenosine (37). ADP has been shown to produce endothelium-dependent NO-mediated vasodilation via activation of the purinergic P2Y receptor, which is at least equipotent to ATP (48, 60). Adenosine, which is also equipotent to ATP (37), produces vasodilation that is primarily endothelium dependent at lower doses, whereas principally endothelium independent at higher doses (45, 65). This may explain our previous findings in normal swine that the vasodilation produced by ATP in doses of 300-500 µg · kg-1 · min-1 was only partially attenuated by nitro-L-arginine (15). The finding that the vasodilator response to nitroprusside was maintained suggests that vascular smooth muscle responsiveness is unaltered and hence that the endothelium-independent component of adenosine-induced vasodilation would likely be unperturbed. Thus, if ATP infusion in MI would have resulted in higher adenosine levels, this would have led to a greater degree of endothelium-independent vasodilation, which could then actually have contributed to an underestimation of the degree of endothelial dysfunction. Although we cannot entirely exclude that ATP breakdown to ADP and adenosine was enhanced in MI, the finding that the vasodilator response to ATP infusion was blunted in the MI group compared with the N group is in agreement with the hypothesis that agonist-induced (ATP, ADP, and adenosine) endothelium-dependent NO-mediated vasodilation is blunted in swine with LV dysfunction 2-3 wk after infarction.

Basal NO biological availability. A loss of NO-mediated vasodilation in heart failure could contribute to reduced tissue perfusion. In addition, the peripheral vasoconstriction can increase the work load of the heart, which together with an increased coronary vasomotor tone, may lead to myocardial ischemia thereby aggravating LV dysfunction and enhancing the progression of LV dysfunction to heart failure. This is supported by studies in dogs with pacing-induced dilated cardiomyopathy, in which the loss of basal NO production in the LV myocardium coincides with the progression from LV dysfunction to overt heart failure (47, 58). In contrast, we found no evidence of a reduced vasodilator influence of endogenous NO represented by the similar decreases in (regional) systemic, pulmonary, and coronary conductances produced by L-NNA (blocking both eNOS and iNOS) in resting swine, 2-3 wk after MI. Similar observations were made in rats in which up to 13 wk after a large MI (40% of the left ventricle), constrictor responses to the NO synthase inhibitor Nomega -nitro-monomethyl-L-arginine (L-NMMA) were not different from those in normal rats in the total systemic bed (21) and resistance vessels in the renal, cutaneous, mesenteric, cerebral, and hindlimb microcirculation (6, 10, 13). Only in the coronary bed was vasoconstriction by L-NMMA less at 8 wk after MI compared with normal rats (10). In humans with chronic heart failure, studies on the contribution of NO to basal microvascular tone in the forearm, leg, or total systemic bed have yielded equivocal results with responses to NO synthase inhibition varying from decreased (25, 31, 32, 41), maintained (38), to enhanced (11, 23) vasoconstriction. It is possible that a maintained or increased production of NO that was observed in some studies was the result of increased expression of iNOS (12, 44) as part of a generalized inflammatory response in end-stage heart failure, which occurred in the presence of either a decreased (12, 49) or increased (20, 27) expression of eNOS. Interestingly, iNOS upregulation has been suggested to be of greater importance in idiopathic dilated cardiomyopathy than in ischemic cardiomyopathy (7), although this could not be confirmed by others (20, 26, 51). An explanation for the equivocal findings in clinical studies could lie in differences in severity and etiology of heart failure. However, most clinical studies used patient populations that consisted of mixed etiology and a range of severities, which makes interpretation and comparison of these studies difficult.

The inflammatory reaction that occurs after MI not only causes an increase in reactive oxygen species (22), but could also upregulate iNOS (12, 44), particularly in the myocardium (52). Consequently, in the present study, iNOS-mediated NO production could have increased and thereby have masked a possible reduction in eNOS activity. Because L-NNA, in the concentration used, blocks all three isoforms of NOS (5), we performed additional experiments in which we blocked iNOS with aminoguanidine in a dose of 20 mg/kg iv. This dose was based on studies in rabbits, in which a dose of 10 mg/kg aminoguanidine reduced cGMP levels and blocked iNOS activity by over 80% (59), and in rats, in which a dose of 15 mg/kg iv prevented and reversed endotoxic shock-induced systemic hypotension (62). More recently, a study was published that reported that 30 mg/kg, administered subcutaneously, completely abolished the induction of iNOS activation and cardioprotection by monophosphoryl lipid A in swine during a 24-h period (64). Hence, the dose of aminoguanidine of 20 mg/kg given intravenously 10 min before the exercise trial will produce effective blockade of iNOS. The observation that iNOS blockade had no effect on either basal systemic, pulmonary, or coronary vascular tone is in agreement with the hypothesis that NO production via iNOS does not contribute significantly to vascular tone in MI swine, and consequently that basal endothelial NO production is maintained early after MI despite the presence of LV dysfunction.

It could also be argued that endothelial NO production was already maximal so that ATP could not result in any further stimulation of NO production. However, this is unlikely because ATP did produce, albeit blunted, vasodilation in MI. Finally, ATP may activate eNOS through a different mechanism than shear stress; the latter is present in blood vessels in vivo, even under resting conditions. Indeed, ATP-induced activation of eNOS is mediated through a calcium-calmodulin-dependent pathway (42), whereas shear stress activates eNOS through Akt-mediated phosphorylation (8), resulting in calcium-independent activation of eNOS. Hence, it is possible that perturbations in the calcium homeostasis of endothelial cells contributed to the selective impairment of ATP-induced vasodilation in swine with MI.

NO Availability During Treadmill Exercise

A loss of endothelial NO-mediated vasodilator influence in heart failure could contribute to impaired tissue perfusion, when myocardial O2 demand is increased such as during exercise. The exercise-induced vasodilation in the systemic and pulmonary beds of the MI group during control was similar to the vasodilation observed in the normal group during exercise in the presence of L-NNA, which might suggest that a loss of NO production contributed to the blunted systemic and pulmonary vasodilation in MI. However, the effects of L-NNA were similar in MI and N swine, both at rest and during exercise. This observation implies that while agonist-induced receptor-mediated NO production was reduced, the exercise-induced NO production was maintained. Several possibilities might explain the difference between agonist- and exercise-induced NO production. First, Traverse et al. (54) have shown that the amount of NO produced after stimulation with an agonist is larger than the amount of NO produced with moderate exercise (60% increase in heart rate). Hence, the maximal capacity of NO production may be reduced, whereas the capacity of eNOS is sufficient to maintain basal and exercise-induced NO production. This explanation is unlikely because agonist-induced dilation is already affected at the lowest dose of ATP administered (which probably releases less NO than strenuous exercise), and higher doses of ATP still produce more dilation. Second, as stated above, ATP may activate eNOS through a different mechanism than shear stress (8, 42), so that calcium homeostasis of endothelial cells is selectively affected by MI.

Similar to the systemic bed as a whole, we also observed similar responses to L-NNA in regional vascular beds in MI and N swine. In patients with chronic heart failure [ejection fraction 22%, NYHA class II-III; (32)] inhibition of NO production by L-NMMA had no effect on forearm blood flow either at rest or during exercise. In contrast, L-NMMA decreased forearm blood flow and vascular conductance in normal subjects both at rest and during handgrip exercise. Interpretation of that study is difficult, however, because forearm blood flow was measured with venous occlusion plethysmography, which requires interruption of exercise and the measurements reflect blood flow during the early recovery from exercise. Indeed, Radegran and Saltin (46) have recently shown that inhibition of NO hastens the recovery of blood flow following exercise but does not reduce skeletal muscle blood flow during exercise. In rats with heart failure produced by a 6-wk-old MI, inhibition of NO production elicited smaller decreases in slow oxidative (i.e., red) skeletal muscle blood flow and vascular conductance, compared with normal rats (27a). In contrast, in the present study L-NNA had no effect on skeletal muscle blood flow in either normal or MI swine, whereas L-NNA-induced decrease in skeletal muscle vascular conductance was similar in MI and N swine in both red and white muscle groups.

Possible Causes for Increased Vascular Tone After MI

The present findings indicate that a reduction in NO production does not contribute to the increased tone of the systemic, pulmonary, and coronary resistance vessels at rest and the reduced dilatory response in these beds to exercise in 2-3 wk after MI. We (24) previously found that early after infarction, the neurohumoral status has changed so that circulating levels of endothelin, norepinephrine, epinephrine, and angiotensin II increased more during exercise in MI than in N groups, which may have contributed to the decreased dilator response to exercise. Also, other vasodilator systems, such as prostacyclin, exert a tonic vasodilator influence in pigs (1). Because prostacyclin has been shown to contribute to shear stress-induced vasodilation (36) and its production from endogenously administered arachidonic acid is reduced in the large coronary arteries of dogs with pacing-induced heart failure (63), a reduced prostacyclin production may also have contributed to the increased peripheral resistance at rest and during exercise.

In conclusion, although agonist-induced vasodilation is already blunted, basal and exercise-induced production of NO are maintained in swine with moderate LV dysfunction 2-3 wk after MI.


    ACKNOWLEDGEMENTS

The authors gratefully acknowledge Rob H. van Bremen and René Stubenitsky for technical assistance.


    FOOTNOTES

D. J. Duncker is the recipient of an Established Investigator stipend from the Netherlands Heart Foundation (2000D038). D. Merkus is supported by a postdoc stipend from The Netherlands Heart Foundation (2000D042).

Address for reprint requests and other correspondence: DJ Duncker, Experimental Cardiology, Thoraxcenter, Erasmus Univ. Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands (E-mail: duncker{at}tch.fgg.eur.nl).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

First published February 21, 2002;10.1152/ajpheart.00834.2001

Received 24 September 2001; accepted in final form 13 February 2002.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Albertini, M, Vanelli G, and Clement MG. PGI2 and nitric oxide involvement in the regulation of systemic and pulmonary basal vascular tone in the pig. Prostaglandins Leukot Essent Fatty Acids 54: 273-278, 1996[Web of Science][Medline].

2.   Baggia, S, Perkins K, and Greenberg B. Endothelium-dependent relaxation is not uniformly impaired in chronic heart failure. J Cardiovasc Pharmacol 29: 389-396, 1997[Web of Science][Medline].

3.   Bank, AJ, Lee PC, and Kubo SH. Endothelial dysfunction in patients with heart failure: relationship to disease severity. J Card Fail 6: 29-36, 2000[Web of Science][Medline].

4.   Bauersachs, J, Bouloumie A, Fraccarollo D, Hu K, Busse R, and Ertl G. Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production. Circulation 100: 292-298, 1999.

5.   Boer, R, Ulrich WR, Klein T, Mirau B, Haas S, and Baur I. The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes. Mol Pharmacol 58: 1026-1034, 2000[Abstract/Free Full Text].

6.   Ceiler, DL, Nelissen-Vrancken M, De Mey JG, and Smits JF. Role of basal nitric oxide synthesis in vasoconstrictor hyporeactivity in the perfused rat hindlimb after myocardial infarction: effect of captopril. Cardiovasc Res 43: 779-787, 1999[Abstract/Free Full Text].

7.   De Belder, AJ, Radomski MW, Why HJ, Richardson PJ, and Martin JF. Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart disease. Br Heart J 74: 426-430, 1995[Abstract/Free Full Text].

8.   Dimmeler, S, Fleming I, Fisslthaler B, Hermann C, Busse R, and Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt- dependent phosphorylation. Nature 399: 601-605, 1999[Medline].

9.   Drexler, H, Flaim SF, Toggart EJ, Glick MR, and Zelis R. Cardiocirculatory adjustments to exercise following myocardial infarction in rats. Basic Res Cardiol 81: 350-360, 1986[Web of Science][Medline].

10.   Drexler, H, Hablawetz E, Lu W, Riede U, and Christes A. Effects of inhibition of nitric oxide formation on regional blood flow in experimental myocardial infarction. Circulation 86: 255-262, 1992.

11.   Drexler, H, Hayoz D, Munzel T, Hornig B, Just H, Brunner HR, and Zelis R. Endothelial function in chronic congestive heart failure. Am J Cardiol 69: 1596-1601, 1992[Web of Science][Medline].

12.   Drexler, H, Kastner S, Strobel A, Studer R, Brodde OE, and Hasenfuss G. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart. J Am Coll Cardiol 32: 955-963, 1998[Abstract/Free Full Text].

13.   Drexler, H, and Lu W. Endothelial dysfunction of hindquarter resistance vessels in experimental heart failure. Am J Physiol Heart Circ Physiol 262: H1640-H1645, 1992[Abstract/Free Full Text].

14.   Duncker, DJ, Haitsma DB, van der Geest IE, Stubenitsky R, Van Meegen JR, Man in't Veld AJ, and Verdouw PD. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist Z1046 in awake pigs at rest and during treadmill exercise. Br J Pharmacol 120: 1101-1113, 1997[Web of Science][Medline].

15.   Duncker, DJ, Stubenitsky R, Tonino PA, and Verdouw PD. Nitric oxide contributes to the regulation of vasomotor tone but does not modulate O2-consumption in exercising swine. Cardiovasc Res 47: 738-748, 2000[Abstract/Free Full Text].

16.   Duncker, DJ, Stubenitsky R, and Verdouw PD. Autonomic control of vasomotion in the porcine coronary circulation during treadmill exercise: evidence for feed-forward beta-adrenergic control. Circ Res 82: 1312-1322, 1998[Abstract/Free Full Text].

17.   Duncker, DJ, Stubenitsky R, and Verdouw PD. Role of adenosine in the regulation of coronary blood flow in swine at rest and during treadmill exercise. Am J Physiol Heart Circ Physiol 275: H1663-H1672, 1998[Abstract/Free Full Text].

18.   Elsner, D, Muntze A, Kromer EP, and Riegger GA. Systemic vasoconstriction induced by inhibition of nitric oxide synthesis is attenuated in conscious dogs with heart failure. Cardiovasc Res 25: 438-440, 1991[Web of Science][Medline].

19.   Francis, GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, Kubo SH, Rudin-Toretsky E, and Yusuf S. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 82: 1724-1729, 1990.

20.   Fukuchi, M, Hussain SN, and Giaid A. Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure: their relation to lesion site and beta-adrenergic receptor therapy. Circulation 98: 132-139, 1998.

21.   Gaballa, MA, Raya TE, Hoover CA, and Goldman S. Effects of endothelial and inducible nitric oxide synthases inhibition on circulatory function in rats after myocardial infarction. Cardiovasc Res 42: 627-635, 1999[Abstract/Free Full Text].

22.   Govers, R, and Rabelink TJ. Cellular regulation of endothelial nitric oxide synthase. Am J Physiol Renal Physiol 280: F193-F206, 2001[Abstract/Free Full Text].

23.   Habib, F, Dutka D, Crossman D, Oakley CM, and Cleland JG. Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism? Lancet 344: 371-373, 1994[Web of Science][Medline].

24.   Haitsma, DB, Bac D, Raja N, Boomsma F, Verdouw PD, and Duncker DJ. Minimal impairment of myocardial blood flow responses to exercise in the remodeled left ventricle early after myocardial infarction, despite significant hemodynamic and neurohumoral alterations. Cardiovasc Res 52: 471-428, 2001.

25.   Hambrecht, R, Fiehn E, Weigl C, Gielen S, Hamann C, Kaiser R, Yu J, Adams V, Niebauer J, and Schuler G. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 98: 2709-2715, 1998.

26.   Haywood, GA, Tsao PS, von der Leyen HE, Mann MJ, Keeling PJ, Trindade PT, Lewis NP, Byrne CD, Rickenbacher PR, Bishopric NH, Cooke JP, McKenna WJ, and Fowler MB. Expression of inducible nitric oxide synthase in human heart failure. Circulation 93: 1087-1094, 1996.

27.   Heymes, C, Vanderheyden M, Bronzwaer JG, Shah AM, and Paulus WJ. Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy. Circulation 99: 3009-3016, 1999.

27a.   Hirai, T, Zelis R, and Musch TI. Effects of nitric oxide synthase inhibition on the muscle blood flow response to exercise in rats with heart failure. Cardiovasc Res 30: 469-476, 1995[Web of Science][Medline].

28.   Hirooka, Y, Imaizumi T, Tagawa T, Shiramoto M, Endo T, Ando S, and Takeshita A. Effects of L-arginine on impaired acetylcholine-induced and ischemic vasodilation of the forearm in patients with heart failure. Circulation 90: 658-668, 1994.

29.   Kaiser, L, Spickard RC, and Olivier NB. Heart failure depresses endothelium-dependent responses in canine femoral artery. Am J Physiol Heart Circ Physiol 256: H962-H967, 1989[Abstract/Free Full Text].

30.   Katz, SD, Biasucci L, Sabba C, Strom JA, Jondeau G, Galvao M, Solomon S, Nikolic SD, Forman R, and LeJemtel TH. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol 19: 918-925, 1992[Abstract].

31.   Katz, SD, Khan T, Zeballos GA, Mathew L, Potharlanka P, Knecht M, and Whelan J. Decreased activity of the L-arginine-nitric oxide metabolic pathway in patients with congestive heart failure. Circulation 99: 2113-2117, 1999.

32.   Katz, SD, Krum H, Khan T, and Knecht M. Exercise-induced vasodilation in forearm circulation of normal subjects and patients with congestive heart failure: role of endothelium-derived nitric oxide. J Am Coll Cardiol 28: 585-590, 1996[Abstract].

33.   Katz, SD, Schwarz M, Yuen J, and LeJemtel TH. Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors. Circulation 88: 55-61, 1993.

34.   Kiowski, W, Sutsch G, Schalcher C, Brunner HP, and Oechslin E. Endothelial control of vascular tone in chronic heart failure. J Cardiovasc Pharmacol 32: S67-S73, 1998.

35.   Kiuchi, K, Sato N, Shannon RP, Vatner DE, Morgan K, and Vatner SF. Depressed beta-adrenergic receptor- and endothelium-mediated vasodilation in conscious dogs with heart failure. Circ Res 73: 1013-1023, 1993[Abstract/Free Full Text].

36.   Koller, A, Sun D, and Kaley G. Role of shear stress and endothelial prostaglandins in flow- and viscosity-induced dilation of arterioles in vitro. Circ Res 72: 1276-1284, 1993[Abstract/Free Full Text].

37.   Korchazhkina, O, Wright G, and Exley C. Intravascular ATP and coronary vasodilation in the isolated working rat heart. Br J Pharmacol 127: 701-708, 1999[Web of Science][Medline].

38.   Kubo, SH, Rector TS, Bank AJ, Raij L, Kraemer MD, Tadros P, Beardslee M, and Garr MD. Lack of contribution of nitric oxide to basal vasomotor tone in heart failure. Am J Cardiol 74: 1133-1136, 1994[Web of Science][Medline].

39.   Kubo, SH, Rector TS, Bank AJ, Williams RE, and Heifetz SM. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 84: 1589-1596, 1991.

40.   Lindsay, DC, Jiang C, Brunotte F, Adamopoulos S, Coats AJ, Rajagopalan B, Poole-Wilson PA, and Collins P. Impairment of endothelium dependent responses in a rat model of chronic heart failure: effects of an exercise training protocol. Cardiovasc Res 26: 694-697, 1992[Abstract/Free Full Text].

41.   Maguire, SM, Nugent AG, McGurk C, Johnston GD, and Nicholls DP. Abnormal vascular responses in human chronic cardiac failure are both endothelium dependent and endothelium independent. Heart 80: 141-145, 1998[Abstract/Free Full Text].

42.   Motte, S, Communi D, Pirotton S, and Boeynaems JM. Involvement of multiple receptors in the actions of extracellular ATP: the example of vascular endothelial cells. Int J Biochem Cell Biol 27: 1-7, 1995[Web of Science][Medline].

43.   Ontkean, M, Gay R, and Greenberg B. Diminished endothelium-derived relaxing factor activity in an experimental model of chronic heart failure. Circ Res 69: 1088-1096, 1991[Abstract/Free Full Text].

44.   Orus, J, Heras M, Morales-Ruiz M, Leivas A, Roig E, Rigol M, Rivera F, Sanz G, and Jimenez W. Nitric oxide synthase II mRNA expression in cardiac tissue of patients with heart failure undergoing cardiac transplantation. J Heart Lung Transplant 19: 139-144, 2000[Web of Science][Medline].

45.   Quillen, JE, and Harrison DG. Vasomotor properties of porcine endocardial and epicardial microvessels. Am J Physiol Heart Circ Physiol 262: H1143-H1148, 1992[Abstract/Free Full Text].

46.   Radegran, G, and Saltin B. Nitric oxide in the regulation of vasomotor tone in human skeletal muscle. Am J Physiol Heart Circ Physiol 276: H1951-H1960, 1999[Abstract/Free Full Text].

47.   Recchia, FA, McConnell PI, Bernstein RD, Vogel TR, Xu X, and Hintze TH. Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. Circ Res 83: 969-979, 1998[Abstract/Free Full Text].

48.   Simonsen, U, Garcia-Sacristan A, and Prieto D. Involvement of ATP in the non-adrenergic non-cholinergic inhibitory neurotransmission of lamb isolated coronary small arteries. Br J Pharmacol 120: 411-420, 1997[Web of Science][Medline].

49.   Smith, CJ, Sun D, Hoegler C, Roth BS, Zhang X, Zhao G, Xu XB, Kobari Y, Pritchard K, Jr, Sessa WC, and Hintze TH. Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure. Circ Res 78: 58-64, 1996[Abstract/Free Full Text].

50.   Spinale, FG, de Gasparo M, Whitebread S, Hebbar L, Clair MJ, Melton DM, Krombach RS, Mukherjee R, Iannini JP, and O SJ. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure. I. Effects on left ventricular performance and neurohormonal systems. Circulation 96: 2385-2396, 1997.

51.   Stein, B, Eschenhagen T, Rudiger J, Scholz H, Forstermann U, and Gath I. Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure. J Am Coll Cardiol 32: 1179-1186, 1998[Abstract/Free Full Text].

52.   Takimoto, Y, Aoyama T, Keyamura R, Shinoda E, Hattori R, Yui Y, and Sasayama S. Differential expression of three types of nitric oxide synthase in both infarcted and non-infarcted left ventricles after myocardial infarction in the rat. Int J Cardiol 76: 135-145, 2000[Web of Science][Medline].

53.   Teerlink, JR, Clozel M, Fischli W, and Clozel JP. Temporal evolution of endothelial dysfunction in a rat model of chronic heart failure. J Am Coll Cardiol 22: 615-620, 1993[Abstract].

54.   Traverse, JH, Wang YL, Du R, Nelson D, Lindstrom P, Archer SL, Gong G, and Bache RJ. Coronary nitric oxide production in response to exercise and endothelium-dependent agonists. Circulation 101: 2526-2531, 2000.

55.   Treasure, CB, Vita JA, Cox DA, Fish RD, Gordon JB, Mudge GH, Colucci WS, Sutton MG, Selwyn AP, Alexander RW, and Ganz P. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation 81: 772-779, 1990.

56.   Van Kats, JP, Duncker DJ, Haitsma DB, Schuijt MP, Niebuur R, Stubenitsky R, Boomsma F, Schalekamp MA, Verdouw PD, and Danser AH. Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction: role of tissue angiotensin II. Circulation 102: 1556-1563, 2000.

57.   Varin, R, Mulder P, Richard V, Tamion F, Devaux C, Henry JP, Lallemand F, Lerebours G, and Thuillez C. Exercise improves flow-mediated vasodilatation of skeletal muscle arteries in rats with chronic heart failure. Role of nitric oxide, prostanoids, and oxidant stress. Circulation 99: 2951-2957, 1999.

58.   Wang, J, Seyedi N, Xu XB, Wolin MS, and Hintze TH. Defective endothelium-mediated control of coronary circulation in conscious dogs after heart failure. Am J Physiol Heart Circ Physiol 266: H670-H680, 1994[Abstract/Free Full Text].

59.   Wildhirt, SM, Weismueller S, Schulze C, Conrad N, Kornberg A, and Reichart B. Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to myocardial dysfunction and extent of infarct size in rabbits: evidence for a late phase of nitric oxide-mediated reperfusion injury. Cardiovasc Res 43: 698-711, 1999[Abstract/Free Full Text].

60.   Wilkinson, GF, McKechnie K, Dainty IA, and Boarder MR. P2Y purinoceptor and nucleotide receptor-induced relaxation of precontracted bovine aortic collateral artery rings: differential sensitivity to suramin and indomethacin. J Pharmacol Exp Ther 268: 881-887, 1994[Abstract/Free Full Text].

61.   Wolff, DJ, Lubeskie A, Gauld DS, and Neulander MJ. Inactivation of nitric oxide synthases and cellular nitric oxide formation by N6-iminoethyl-L-lysine and N5-iminoethyl-L-ornithine. Eur J Pharmacol 350: 325-334, 1998[Web of Science][Medline].

62.   Wu, CC, Chen SJ, Szabo C, Thiemermann C, and Vane JR. Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br J Pharmacol 114: 1666-1672, 1995[Web of Science][Medline].

63.   Yi, GH, Zwas D, and Wang J. Chronic exercise training preserves prostaglandin-induced dilation of epicardial coronary artery during development of heart failure in awake dogs. Prostaglandins Other Lipid Mediat 60: 137-151, 2000[Web of Science][Medline].

64.   Yoshida, T, Engelman RM, Engelman DT, Rousou JA, Maulik N, Sato M, Elliott GT, and Das DK. Preconditioning of swine heart with monophosphoryl lipid A improves myocardial preservation. Ann Thorac Surg 70: 895-900, 2000[Abstract/Free Full Text].

65.   Zhang, C, Hein TW, and Kuo L. Transmural difference in coronary arteriolar dilation to adenosine: effect of luminal pressure and K(ATP) channels. Am J Physiol Heart Circ Physiol 279: H2612-H2619, 2000[Abstract/Free Full Text].

Am J Physiol Heart Circ Physiol 282(6):H2198-H2209
0363-6135/02 $5.00 Copyright © 2002 the American Physiological Society


This article has been cited by other articles:


Home page
 J. Physiol.Home page
D. Merkus, B. Houweling, V. J. de Beer, Z. Everon, and D. J. Duncker
Alterations in endothelial control of the pulmonary circulation in exercising swine with secondary pulmonary hypertension after myocardial infarction
J. Physiol., May 1, 2007; 580(3): 907 - 923.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. Merkus, D. B. Haitsma, O. Sorop, F. Boomsma, V. J. de Beer, J. M. J. Lamers, P. D. Verdouw, and D. J. Duncker
Coronary vasoconstrictor influence of angiotensin II is reduced in remodeled myocardium after myocardial infarction
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2082 - H2089.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
B. Houweling, D. Merkus, O. Sorop, F. Boomsma, and D. J. Duncker
Role of endothelin receptor activation in secondary pulmonary hypertension in awake swine after myocardial infarction
J. Physiol., July 15, 2006; 574(2): 615 - 626.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. Merkus, B. Houweling, M. van Vliet, and D. J. Duncker
Contribution of KATP+ channels to coronary vasomotor tone regulation is enhanced in exercising swine with a recent myocardial infarction
Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1306 - H1313.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. Merkus, B. Houweling, A. H. van den Meiracker, F. Boomsma, and D. J. Duncker
Contribution of endothelin to coronary vasomotor tone is abolished after myocardial infarction
Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H871 - H880.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/6/H2198    most recent
00834.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haitsma, D. B.
Right arrow Articles by Duncker, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haitsma, D. B.
Right arrow Articles by Duncker, D. J.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online